Skip to main content
OpenTrials
Completed

NCT Number: NCT07193108

The 30-15 Intermittent Fitness Test Provides Superior Sport-Specific Sensitivity to Treadmill Testing in Elite Female Footballers

This study compares the acute aerobic, metabolic, and threshold-related physiological responses elicited by the 30-15 Intermittent Fitness Test (30-15IFT) and a treadmill-based incremental running test in elite female football players. Using a randomized crossover design, all participants completed both testing protocols with a 48-hour recovery period. Outcomes included maximal oxygen uptake, maximal running speed, heart rate responses, lactate-derived thresholds, metabolic tolerance indices, and recovery markers.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–30 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Gumushane Univetsity

Gümüşhane, Kelkit, 29600, Turkey (Türkiye)

About this study

Laboratory-based treadmill tests are commonly used to assess aerobic capacity in football players; however, they lack sport-specific characteristics such as intermittent running, accelerations, and changes of direction. The 30-15 Intermittent Fitness Test (30-15IFT) has been proposed as a more ecologically valid field-based alternative.

Twenty-seven elite female football players competing in the Turkish Women's Super League completed both the 30-15IFT and a standardized treadmill incremental protocol in a randomized crossover design. Tests were separated by 48 hours and performed under controlled environmental conditions. Physiological variables including VO₂max, maximal running speed, maximal heart rate, respiratory exchange ratio, lactate-derived thresholds (OBLA), metabolic load-dependent tolerance, and post-exercise recovery markers were assessed using breath-by-breath gas analysis, heart rate monitoring, and capillary blood lactate sampling.

The study aims to determine whether the 30-15IFT elicits more sensitive and sport-specific physiological responses compared with treadmill testing, thereby supporting its use in performance monitoring and individualized training prescription in elite women's football.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female football players aged 18-35 years
  • Competing in the Turkish Women's Super League
  • Minimum of 3 years of professional football experience,
  • Full participation in training and matches during the previous 6 months,
  • Ability to perform maximal exercise testing

Exclusion criteria

  • Musculoskeletal injury affecting performance within the last 3 months,
  • Diagnosed cardiovascular, metabolic, or respiratory disease,
  • Any condition limiting maximal physical effort

Treatment and study plan

30-15 Intermittent Fitness Test

Other

Participants performed the 30-15 Intermittent Fitness Test consisting of 30-second running bouts interspersed with 15-second passive recovery periods, with progressive increases in running speed until volitional exhaustion.

Control

Other

Inspiratory Muscle Warm-Up Non-treated group, Control

Primary outcomes

  1. Maximal Running Speed (MRS)

    Time frame: DAY 1

    Highest running speed achieved during each protocol.

  2. Maximal Oxygen Uptake (VO₂max)

    Time frame: Day 1

    Maximal oxygen uptake measured via breath-by-breath gas analysis.

Secondary outcomes

  1. body composition

    Time frame: 1 Day

    Body composition (BMI)

  2. Maximal Heart Rate (HRmax)

    Time frame: 1 Day

    Peak heart rate achieved during each test.

  3. Maximal Oxygen Uptake (VO₂max)

    Time frame: DAY 1

    Maximal oxygen uptake measured via breath-by-breath gas analysis.

Sponsors and collaborators

Lead sponsor

Gümüşhane Universıty

Other

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Sep 25, 2025
Registry last updated
Feb 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.